|
LOC646214 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.057800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.262200E-01 |
| Normal-vs-Stage2 |
9.991600E-02 |
| Normal-vs-Stage3 |
1.299580E-01 |
| Normal-vs-Stage4 |
2.436000E-01 |
| Stage1-vs-Stage2 |
9.237900E-02 |
| Stage1-vs-Stage3 |
5.226400E-02 |
| Stage1-vs-Stage4 |
1.458990E-01 |
| Stage2-vs-Stage3 |
3.524800E-01 |
| Stage2-vs-Stage4 |
4.336200E-01 |
| Stage3-vs-Stage4 |
9.125400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.647200E-01 |
| Normal-vs-AfricanAmerican |
2.821600E-02 |
| Normal-vs-Asian |
9.013800E-02 |
| Caucasian-vs-AfricanAmerican |
3.607600E-02 |
| Caucasian-vs-Asian |
2.131200E-01 |
| AfricanAmerican-vs-Asian |
3.060900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.446400E-01 |
| Normal-vs-Female |
1.779960E-02 |
| Male-vs-Female |
2.174300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.918600E-01 |
| Normal-vs-Extreme_Weight |
9.154200E-01 |
| Normal-vs-Obese |
1.343200E-01 |
| Normal-vs-Extreme_Obese |
9.701200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.351200E-01 |
| Normal_Weight-vs-Obese |
3.640600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.379000E-01 |
| Extreme_Weight-vs-Obese |
1.153230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.790600E-01 |
| Obese-vs-Extreme_Obese |
2.387000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.542650E-01 |
| Normal-vs-Age(41-60Yrs) |
3.990000E-02 |
| Normal-vs-Age(61-80Yrs) |
9.350800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.436040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.686200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.087230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.387600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.222400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.441310E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.445900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.299600E-01 |
| Normal-VS-Type2 PRCC |
9.640600E-01 |
| Normal-VS-KIRP CIMP |
3.220000E-04 |
| Normal-VS-Unclassified PRCC |
1.016020E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.868200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.997900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.606640E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.844800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.104800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.311800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.388800E-01 |
| Normal-vs-N1 |
3.207500E-02 |
| Normal-vs-N2 |
7.950400E-01 |
| N0-vs-N1 |
1.378390E-02 |
| N0-vs-N2 |
9.650000E-01 |
| N1-vs-N2 |
2.807800E-01 |
|
|
